Member Info for ratcliffewriter

Thinking back to some months ago, I never thought I'd be wanting this to go into the 9s!

'The casual observer, new to SCLP May see this as increasing cash burn' - The casual observer, new to SCLP may also see this as a significant and timely addition of key staff at a crucial period. I doubt it is likely to induce a panic sell somehow!

The fat lady has not yet burst into song.

What you say is correct Ruck, it is indeed none of your business.

Are you serious Dracula1? "Most genuine Investors are not bothered by P+Ds etc" - try telling that to the people who have unrecoverable averages when they bought in good faith on the 70p spike only to find there was no reason for it, yet so many of the P and D crew were lying through their back teeth to ramp it up.

The analogy of a motorway journey is a good one, and buying a share on AIM is more like driving in fog a lot of the time. But while each driver may have a different objective and distance in mind, if the signs read 'new bridge opening tomorrow' but when you got there you found it had barely been started and they wanted you to cough up a toll before they carried on with it, very few drivers would be singing the praises of the bridgebuilders I suspect.

So if I'd dived in with a couple of grand with the sp at 7p I'd be entitled to say the company is in trouble or badly run, but expected to say it's going great guns and headed for success. But the fact I thought it had some issues at 7p, and was proved correct as I watch it drop sub 1p means that I can't comment? Doesn't that actually show that my judgement and analysis of the share is actually more perceptive than those who are just pumping it to recoup losses? Or to be fair, watching for a better future - but living on baseless optimism rather than factual references and external validations? I think your assessment and the grounds for it need clarifying Valju.

Do you really expect him to tell you Isleworth? Or more to the point do you feel he has any obligation to?

Pure hypothesis, but there was at least one ii t the last placing who (as I recall) had a policy of investing short term for high returns. Purely an example, but if they had bought whatever quantity at 10p with a view to holding for less than 12 months, they would have had ample opportunity to sell in the low to mid teens, say an average of 12 to 14p, and now is the time to move on within their normal time frame - so selling the residue at around 8p could still leave a profit across the whole fund and also stay within their normal investment strategy. Complete speculation, but it fits one interpretation anyway.

How does that work Valju, when you say "because if its a lot, then you would not be negative"? Does that mean that if you are underwater big time, then you can do nothing but ramp and have a narrower view? It might explain a lot of the posts here - maybe not all paid rampers, just trying to pump it up for a better exit point.

Indeed it would Jonbhoy. If there were some concrete proof via RNS then a buy-in would be an option.

A small tick up to 8.10, and a bit later a 176k buy at full ask 8.50, then a 200k sell at 8.10. I wonder what the rest of today and this week has in store. All nice and calm anyway.

Post reported. It's for the best.

I'm all ears - let Paulie show me where the RNSs say that val 401 and val 201 'works extremely well' and we can take it from there.

There's a big difference between opinions backed up by facts and justifiable conjecture, versus irresponsible ramping in denial of the blindingly obvious. Can I suggest you ring the fire brigade Freddie, because there's a strong smell of burning martyr in your post, even if it is on the wrong board.

I've studied the RNSs pretty carefully, but can't find anything that says 'val 401 and val 201 works extremely well' as Paulie3 says 'we've been told'. I wonder if Paulie would be good enough to cut and paste it here? Otherwise it is just a prime example of blinkered ramping as highlighted by Chelsea7.

Indeed. Watching for a sensible entry point there, but just a stark view of oblivion looming at the moment.

From what the bid was all day (when I looked, anyway) it looks like a buy, but then if it's a sell it's at a premium to the bid, which for 100k is useful. See what happens on Monday anyway.

It's called research. Granted I only read company RNSs which some here seem to ignore, but basically still seeing if there is a buying opportunity but sharing my thoughts in the meanwhile. Do you have a problem with that?

Re Chelsea7’s prediction of a placing at .35 I looked back at the pattern before the last consolidation, because they can’t issue shares below the nominal value of the shares. I was sceptical that another placing could be brewing so soon, so had a look back to last time. In March 2015 they raised 800,000 pounds by a placing at 0.2 pence per share. This is nearly three times their current ‘label’ price but it was before the last consolidation, so the price today is equivalent to .006p against that .2p of 2015. Satu said at the time of that placing ‘this and our recent placings to raise £1.6 million gross in under three months, is an endorsement of the progress we are making and will provide ValiRx with the means to continue to unlock value for shareholders.’ Make of the second half of that sentence what you will, but there had been a flurry of raising ahead of the announcement which came about 8 weeks later in May 2015 that they were going to consolidate the shares at 125 to 1, otherwise they would be unable to raise any further funds by dilution. So the issued share capital of 3,772,151,750 shares was reorganised into 30,177,214 shares. Four months later in September 2016 they raised £2,450,000, before expenses, through the subscription by YA Global Master SPV Ltd of 8,161,637 new ordinary shares at 30.018p each. Other raisings followed on a regular basis as is well known and I won’t go into detail on those.
Those 30 million post-consolidation shares are now just shy of 600 million, a 20 fold increase, and the share price has dropped by 97 percent, from the 30p at the time of the Yorkville CLN to 0.75p. The market cap of the company is now about 4.8 million, a far cry from raising half that amount in one deal with Yorkville, so the scope for raising any significant amount is diminishing fast. If (as is suggested) a deal is imminent, then the sp would undoubtedly rocket, and I might well kick myself for missing it, but it would need to be very soon indeed. When I read the link to AdamBrown’s tweet today I saw his question about a P3 trial, but the response from Suzy Dilly made no mention of anything specific at all – ‘Next steps will be announced just as soon as plans are confirmed.’ So the plans for the steps aren’t even finalised. If she had said ‘we look forward to a P3 starting in the near future’ or better still ‘by end of Q1, H1 or similar’ then even better. But no – the question from AdamBrown of ‘When do you expect the phase 3 trial to start’ was met with a pure sidestep.
We have now seen two raises in quick succession to raise roughly 1.5 million, which imo strongly echoes the first quarter of 2015. One more raise will see the sp at a point where a further raise will be impossible without consolidating, and at the current mcap things look sufficiently poor that I am still not putting my hand in my pocket for these shares. It is fast reaching the point that even if the science is good, the sands of time are running out .